Academic Journal
Q2Journal of Cardiovascular Pharmacology and Therapeutics
About Journal of Cardiovascular Pharmacology and Therapeutics
Journal of Cardiovascular Pharmacology and Therapeutics is a scholarly journal published by SAGE Publications Ltd. SCImago 2025 lists it in Q2, with an SJR of 0.829 and H-index of 63.
Coverage: 1996-2025. Research categories: Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-04-04. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Cardiac electrophysiology and arrhythmias; Cardiac Ischemia and Reperfusion; Atrial Fibrillation Management and Outcomes; Lipoproteins and Cardiovascular Health; Heart Failure Treatment and Management; Antiplatelet Therapy and Cardiovascular Diseases.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Lipoprotein(a) After HORIZON: Causal Culprit, Risk Marker, or Unfulfilled Therapeutic Promise?
Josip Andelo Borovac, Andrej Belancic
2026-09 · DOI: 10.1177/10742484261492865Adherence to Direct Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation: A Single-Center Retrospective Study
Cuie Chang, Sha Lv, Lingyan Yu, Lingcheng Xu et al.
2026-09 · DOI: 10.1177/10742484261490639Serial Platelet Function-Guided Antiplatelet Modulation After STEMI: A Randomized Pilot Study
Hrvoje Jurin, Irzal Hadžibegović, Jure Samardžić, Joško Bulum et al.
2026-08 · DOI: 10.1177/10742484261483397From Needle to Pill: Oral PCSK9 Inhibition Enters the Lipid-Lowering Armamentarium
Andrej Belancic, Josip Andelo Borovac
2026-08 · DOI: 10.1177/10742484261476920Targeting Aldosterone Biosynthesis in Uncontrolled and Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials of Lorundrostat and Baxdrostat
Ravi Pandey, Muhammad Ahmad, Ali Rohan, Iqra Nurie et al.
2026-07 · DOI: 10.1177/10742484261468508ABCD-GENE Score and Bleeding in Post-PCI Patients: Implications for Guided De-Escalation of Antiplatelet Therapy
James C. Coons, Kathleen Polkowski, Linda Prebehalla, Anson Conrad Smith et al.
2026-06 · DOI: 10.1177/10742484261457268Norepinephrine Versus Dopamine as Vasoactive Therapy in Cardiogenic Shock: Association With 28-Day Mortality in a Retrospective Cohort Study
Suthida Chanchenchop, Supanee Sinphurmsukskul, Krittin Bunditanukul
2026-06 · DOI: 10.1177/10742484261456161Effects of Vericiguat on Peripheral Vascular Function and Resting/Exercise Hemodynamics in Patients With Heart Failure With Reduced Ejection Fraction: An Exploratory Pilot Study
Yohei Funauchi, Toru Takase, Kazuyoshi Kakehi, Masafumi Ueno et al.
2026-06 · DOI: 10.1177/10742484261459258Alterations of Platelet MicroRNAs Associated With Dapagliflozin Treatment in Individuals With Type 2 Diabetes Mellitus
Feng Chen, Xueyan Ding, Feifei Dong, Xinghua Shan et al.
2026-05 · DOI: 10.1177/10742484261452727Shared Genetic Liability Between Heart Failure and Myocardial Infarction Revealed by Genome-Wide Cross-Trait Analysis
Ruikang Liu, Chiyun Sun, Nan Jiang, Yang Liu et al.
2026-05 · DOI: 10.1177/10742484261452728Intravenous Canrenone in Paroxysmal Atrial Fibrillation: A Reappraisal of Clinical Utility
Shameer Tahir
2026-05 · DOI: 10.1177/10742484261429978Comparative Effectiveness of Renin-Angiotensin System Inhibitors in Heart Failure With Nonreduced Ejection Fraction: A Multicenter Cohort Study
Ming-Shyan Lin, Po-Chang Wang, Jung-Jung Chang, Pao-Hsien Chu et al.
2026-05 · DOI: 10.1177/10742484261452742Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction
Didi Yuan, Lian Hu, Yanqing Huang, Haotian Tang et al.
2026-04 · DOI: 10.1177/10742484261440344Factors Associated With Loop Diuretic De-escalation in Patients With Acute Decompensated Heart Failure: The Influence of Guideline Directed Medical Therapy Initiation
Satoshi Hanazawa, Noriko Kohyama, Erika Iwasaki, Kenta Muraoka et al.
2026-03 · DOI: 10.1177/10742484261431652Eleutheroside E Attenuates Doxorubicin-Induced Cardiotoxicity by Suppressing Ferroptosis Through Activation of the Nrf2/SLC7A11/GPX4 Signaling Pathway
Peng Sun, Liheng Chen, Xiangzhou Chen, Xuwei Zhang et al.
2026-03 · DOI: 10.1177/10742484261428559From Indirect Evidence to Head-to-Head Trials in Anticoagulation: Clinical Implications of the COBRRA Moment in DOAC Treatment
Andrej Belancic, Josip Andelo Borovac
2026-03 · DOI: 10.1177/10742484261440329Bringing Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) to a Next Level: Strategies and Vision to Ensure a Sustained Journal Growth
Josip Andelo Borovac
2026-03 · DOI: 10.1177/10742484261436224Optimal Switching Antiplatelet Regimen in Patients with Ticagrelor to a Thienopyridine in Korean Patients (SWAPT-K Study)
Hyoun-Woo Noh, Sung-Hyo Seo, Yong-Lee Kim, Chang-Ok Seo et al.
2026-03 · DOI: 10.1177/10742484261440340Underuse of Guideline-Directed Medical Therapy Across Heart Failure Phenotypes in Older Outpatients: A Multicenter Cross-Sectional Study in Vietnam
Huan Thanh Nguyen, Huong Thi Mai Nguyen, Kieu Dang Phuong Nguyen, Duc Thien Tran et al.
2026-03 · DOI: 10.1177/10742484261438177Factors Associated With the Selection of Anti-Hypertensive Medications: A Retrospective Cross-Sectional Analysis
Aymen Alqurain, Arif Aldihani, Hadeel Almousa, Gofran Alkhalaf et al.
2026-03 · DOI: 10.1177/10742484261431512Reviews
Community Reviews
Version History
October 2, 2026 at 8:42 pm
October 2, 2026